Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$153.08 USD
-0.90 (-0.58%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $153.07 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 18% (46 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.69 | 9.99 |
Current Quarter Estimate | 2.27 | 0.83 | 61.00 |
Year Ago Quarter Estimate | 2.22 | -0.88 | 54.84 |
Next Quarter Estimate | 2.21 | 0.84 | 63.00 |
Next Year Estimate | 9.58 | 6.13 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.07 | 17.00 | 15.67 |
Next Year | 7.76 | 14.80 | 11.34 |
Last 5 Years | 7.40 | 4.20 | 8.10 |
Next 5 Years | 6.20 | 12.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 17.58 | 18.10 |
Price/Book (MRQ) | 2.58 | 2.57 |
Price/Cash Flow (MRFY) | 12.08 | 15.07 |
Dividend Yield | 1.95% | 0.00% |
Net Profit Margin (TTM) | 8.99% | 3.16% |
Return on Equity (TTM) | 15.35% | 9.00% |
Debt to Equity (MRQ) | 0.57 | 30.21 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.